These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24090906)
1. Reply to Dr. Selinger et al.'s letter. Manninen P; Collin P J Crohns Colitis; 2013 Dec; 7(12):e715. PubMed ID: 24090906 [No Abstract] [Full Text] [Related]
2. Cancer surveillance for patients with colonic Crohn's disease: will your patients benefit? Selinger CP; Leong RW; Andrews JM J Crohns Colitis; 2013 Dec; 7(12):e714. PubMed ID: 24055457 [No Abstract] [Full Text] [Related]
3. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008 [TBL] [Abstract][Full Text] [Related]
4. [Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis]. Scharl M; Biedermann L; Rogler G Praxis (Bern 1994); 2014 Jan; 103(3):149-54. PubMed ID: 24468454 [TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. Keshteli AH; Baracos VE; Madsen KL World J Gastroenterol; 2015 Jan; 21(4):1081-90. PubMed ID: 25632180 [TBL] [Abstract][Full Text] [Related]
11. Author reply: To PMID 25644364. Williamson KD; Schoeman M; Andrews JM Intern Med J; 2015 Nov; 45(11):1199. PubMed ID: 26563695 [No Abstract] [Full Text] [Related]
12. Letter: colorectal cancer surveillance in inflammatory bowel disease-a call for systematic reform. Prentice RE; Hollingsworth L; Middleton C; Wilson J Aliment Pharmacol Ther; 2021 Apr; 53(8):953-954. PubMed ID: 33745168 [No Abstract] [Full Text] [Related]
13. [Epidemiology and natural history of chronic inflammatory bowel disease]. Lerebours E; Savoye G; Guedon C Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S76-80. PubMed ID: 12704299 [No Abstract] [Full Text] [Related]
14. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Triantafillidis JK; Nasioulas G; Kosmidis PA Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953 [TBL] [Abstract][Full Text] [Related]
15. Learning to detect flat neoplastic lesions in inflammatory bowel disease. Lightdale CJ Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):xiii-xiv. PubMed ID: 24975539 [No Abstract] [Full Text] [Related]
16. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis--a population-based study from the Danish Crohn Colitis Database. Jakobsen C; Paerregaard A; Munkholm P; Wewer V Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1291-301. PubMed ID: 19581873 [TBL] [Abstract][Full Text] [Related]
17. Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies. Krzystek-Korpacka M; Diakowska D; Bania J; Gamian A Inflamm Bowel Dis; 2014 Jul; 20(7):1147-56. PubMed ID: 24859296 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer in inflammatory bowel disease. Butterworth JR Dig Liver Dis; 2009 May; 41(5):338-9. PubMed ID: 19268635 [No Abstract] [Full Text] [Related]
19. Role of mast cells in colorectal cancer development, the jury is still out. Heijmans J; Büller NV; Muncan V; van den Brink GR Biochim Biophys Acta; 2012 Jan; 1822(1):9-13. PubMed ID: 21146606 [TBL] [Abstract][Full Text] [Related]
20. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]